Sera Prognostics, Inc. - Class A Common Stock (SERA)

Competitors to Sera Prognostics, Inc. - Class A Common Stock (SERA)

Aptitude Health

Aptitude Health focuses on the development of innovative diagnostics and disease management solutions in the reproductive health sector, which overlaps with Sera Prognostics' focus on maternal health diagnostics. They leverage proprietary data to produce insights that help guide treatment decisions, thereby directly competing with Sera's offerings in the maternal and prenatal testing market. Aptitude Health's strong network and data integration capabilities may provide them a competitive edge, allowing them to offer more holistic solutions.

CooperSurgical, Inc.

CooperSurgical offers a wide array of products focused on improving reproductive health, including fertility and pregnancy-related diagnostics. Their offerings are somewhat complementary to Sera Prognostics, as they both seek to address challenges in women's health. However, CooperSurgical's well-established market presence and diverse product range may afford them a stronger competitive position to influence maternal health decisions more broadly.

Hologic, Inc. 

Hologic is a global leader in women's health diagnostics, specializing in various areas including breast health and gynecological testing. They offer advanced technologies that intersect with Sera's maternal health diagnostics, thus providing competitive products in women's health. Hologic's extensive resources, established market dominance, and comprehensive product portfolios give them a competitive advantage over newer entrants like Sera Prognostics.

Natera, Inc. 

Natera, a leader in genetic testing, competes with Sera Prognostics by providing non-invasive prenatal screening (NIPT) and genetic testing services. While Sera focuses on predictive diagnostics for preterm birth and other pregnancy complications, Natera capitalizes on the broader genetic diagnostics market. Natera’s established market presence, extensive customer base, and strong technological advancements in genetics afford them a significant competitive advantage over Sera Prognostics.

Quest Diagnostics 

Quest Diagnostics is a leading provider of diagnostic information services, including prenatal and pregnancy tests that compete with Sera Prognostics' offerings. They have an extensive laboratory network and a broad test portfolio that includes a wide range of maternal health tests. Quest's established national footprint and comprehensive service capabilities place them at a significant advantage over smaller companies like Sera Prognostics.